Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study - Concepedia

Concepedia

Publication | Open Access

Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study

DOI Full Paper Access

106

Citations

29

References

2017

Year

Edward Keystone, Peter C. Taylor, Yoshiya Tanaka, C. Gaich, Amy M. DeLozier, Anna Dudek, Jorge Velasco Zamora, Jose Arturo Covarrubias Cobos, Terence Rooney, Stephanie de Bono,

Annals of the Rheumatic Diseases

References

	Year	Citations

Page 1